CAS: 1239986-50-5
3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)pyrrolidine-2,5-dione
CAS:1239986-50-5
Formula:
C23H19N3O2
Purity:
98%
Molecular weight:
369.4159
Ref: IN-DA009C7P
100mg | To inquire | ||
250mg | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025
3-(5,6-Dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)-pyrrolidine-2,5-dione
CAS:1239986-50-5
Purity:
95.0%
Molecular weight:
369.42401123046875
Ref: 10-F446016
5g | 4,216.00 € | ||
50mg | 165.00 € | ||
100mg | 256.00 € | ||
250mg | 480.00 € | ||
500mg | 805.00 € |
Estimated delivery in United States, on Friday 10 Jan 2025
3-(5,6-Dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)pyrrolidine-2,5-dione
CAS:1239986-50-5
Purity:
0.95
Molecular weight:
369.42g/mol
Ref: 54-OR79170
50mg | 302.00 € | ||
250mg | 941.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
3-{1-azatricyclo[6.3.1.0',¹²]dodeca-2,4,6,8(12)-tetraen-3-yl}-4-(1H-indol-3-yl)pyrrolidine-2,5-dione
CAS:1239986-50-5
Tivantinib is a monoclonal antibody that targets the MET receptor tyrosine kinase and inhibits its …
Formula:
C23H19N3O2
Purity:
Min. 95%
Molecular weight:
369.42 g/mol
Ref: 3D-PZB98650
25mg | Discontinued | Request information | |
50mg | Discontinued | Request information | |
100mg | Discontinued | Request information | |
250mg | Discontinued | Request information | |
500mg | Discontinued | Request information |